Latest filing published 17 May 2010 for SCICLONE PHARMACEUTICALS INC, €29k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Hans P. Schmid: trading record in brief
All filings by Hans P. Schmid on record concern Sciclone Pharmaceuticals Inc. Between 14 December 2007 and 14 May 2010, the trades on record add up to 6 filings.
In open-market terms, that means 3 purchases worth €26k on one side and 1 sale worth €171k on the other. Sales outweigh purchases by €145k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 option exercises. Since January 2010: no purchases and 1 sale on the market.
Half of the purchases are above €7,644 and half below.
Most recently, on 17 May 2010, the filings show an option exercise worth €29k in Sciclone Pharmaceuticals Inc. The latest purchase dates back some time: it was published 6,363 days ago, on 8 June 2009. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Hans P. Schmid
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$1.81Common StockSEC:0001243764-10-000003:0
- 35,000 shares@ US$1.08Common StockSEC:0001243764-10-000003:1
- 55,000 shares@ US$3.84Common StockSEC:0001243764-10-000003:2
- 5,000 shares@ US$2.15Common StockSEC:0000880771-09-000013:0Canonical exit: 6 Sept 2009 (T+90)
- 10,000 shares@ US$1.77Common StockSEC:0000880771-08-000006:0Canonical exit: 18 Aug 2008 (T+90)
- 4,489 shares@ US$2.33Common StockSEC:0001250023-07-000040:0Canonical exit: 13 Mar 2008 (T+90)
6 of 6 declarations